DX3-213B is a highly potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor ( IC 50 =3.6 nM). DX3-213B impairs ATP generation (IC 50 =11 nM), and blocks MIA PaCa-2 cell growth (GI 50 =11 nM). DX3-213B is used for the research of the pancreatic cancer.
Form:Solid
规格
规格或纯度
≥99%
英文名称
DX3-213B
生化机理
DX3-213B 是一种高效口服活性氧化磷酸化(OXPHOS)复合物 I 抑制剂(IC 50 =3.6 nM)。DX3-213B 会损害 ATP 的生成(IC 50 =11 nM),并阻碍 MIA PaCa-2 细胞的生长(GI 50 =11 nM)。DX3-213B 可用于研究